XRTX
Xyratex Ltd.
NASDAQ · Healthcare · Biotechnology · CA
$1.01
−18.55%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 17, 2026
- EPS actual
- -$1.05
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -57.2%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 17, 2026 | — | -$1.05 | — | — |
| May 15, 2026 | — | -$0.58 | — | — |
| Nov 14, 2025 | -$0.32 | -$0.13 | Beat 58.86% | — |
| Aug 14, 2025 | -$0.25 | -$0.19 | Beat 24.00% | — |
| May 21, 2025 | -$0.27 | -$1.24 | Miss -359.26% | — |
| Nov 14, 2024 | -$0.38 | -$0.20 | Beat 47.80% | — |
| Aug 14, 2024 | -$0.50 | $0.06 | Beat 111.98% | — |
| May 15, 2024 | -$0.45 | -$1.24 | Miss -176.54% | — |
| Dec 30, 2023 | — | $0.92 | — | — |
| Aug 14, 2023 | -$1.36 | -$0.81 | Beat 40.44% | — |
| May 15, 2023 | -$1.31 | -$0.99 | Beat 24.44% | — |
| Nov 10, 2022 | -$1.54 | -$0.81 | Beat 47.31% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026